ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Prostate Cancer Patient Groups Consider formation Of Coalition Using the “NBCC Model”

August 16, 1996

Assembly of Scientists, started as a result of conflict of interest controversy, plans Sept. 14 meeting.

September 9, 2005

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992

Sprycell Approved for CML

November 5, 2010

About Face; NCI To Keep Preclinical AIDS Drug Development

December 12, 1986

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010